FAU.de
Deutsch
Login
Home
Publications
Research Data
Research Grants
Equipment
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Spain (ES)
Overview
Projects
(67)
Publications
(4,081)
External partners
(726)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Association of quality of life (QOL) with overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA-3 (ML-3) and ML-7 trials (2021)
Fasching P, Harbeck N, Jerusalem G, Colleoni MA, Neven P, Franke F, De Laurentiis M, et al.
Conference contribution
The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses (2021)
Ruszniewski PB, Caplin ME, Kunz PL, Bodei L, Hendifar AE, Mittra E, Wolin EM, et al.
Conference contribution
PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021)
Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al.
Conference contribution
Intratumorally administered CV8102 in patients with advanced solid tumors: Preliminary results from completed dose escalation in study 008 (2021)
Eigentler T, Heinzerling L, Krauss J, Weishaupt C, Ochsenreither S, Lebbe C, Mohr P, et al.
Conference contribution
Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) plus palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study (2021)
Hurvitz SA, Park YH, Bardia A, Quiroga V, Lopez-Valverde V, Steinseifer J, Moore HM, et al.
Conference contribution
COVID-19 pandemic impact on healthcare professionals treating patients with neuroendocrine tumors (NET): An international NET CONNECT survey (2021)
Hernando J, Lamarca A, Cives M, Caplin ME, Pavel ME
Conference contribution
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects (2021)
Kalinichenko L, Mühle C, Jia T, Anderheiden F, Datz M, Eberle AL, Eulenburg V, et al.
Journal article
LOST IN THE QUEST FOR FLINT: A GRAVETTIAN HUNTING CAMP (USATEGI, BASQUE COUNTRY) (2021)
Calvo A, Arrizabalaga A
Journal article
ICDAR 2021 Competition on On-Line Signature Verification (2021)
Tolosana R, Vera-Rodriguez R, Gonzalez-Garcia C, Fierrez J, Rengifo S, Morales A, Ortega-Garcia J, et al.
Conference contribution
Accelerated bioactive behavior of Nagelschmidtite bioceramics: Mimicking the nano and microstructural aspects of biological mineralization (2021)
Rincón-López JA, Hermann-Muñoz JA, Cinca-Luis N, Fernández-Benavides DA, García-Cano I, Guilemany-Casadamon JM, Boccaccini AR, et al.
Journal article
‹
1
...
164
165
166
167
168
...
409
›